THE WHAT? The European Commission has approved Kimberly-Clark’s US$40 billion acquisition of Kenvue, subject to the divestment of several feminine hygiene brands to address competition concerns in the European market.
THE DETAILS Kimberly-Clark has agreed to sell its feminine hygiene brands across the European Economic Area, including Kotex, Lidie, Camelia and Record, to secure regulatory approval. The Commission identified potential competition concerns in the tampon market, particularly in the Czech Republic, Estonia and Slovakia, where the merger would remove an important supplier. Turkish consumer goods distributor Dilek Gida Uretim has agreed to acquire the divested assets, with the Commission also approving the sale after determining that the company has the financial resources and operational expertise to maintain the business.
THE WHY? The approval removes a significant regulatory obstacle to one of the largest transactions in the global personal care industry, while demonstrating how competition authorities are influencing portfolio restructuring and market concentration in feminine hygiene and consumer health categories.
Source: Reuters
